Kim K S, Ryu S W, Kim Y J, Kim E
Division of Life Science, College of Natural Sciences, Pai-Chai University, Taejon, Korea.
Mol Cells. 1999 Feb 28;9(1):78-83.
This study determined the complete genotype and the frequencies of all four mutations [T6235C (m1), A4889G (m2), T5639C (m3) and C4887A (m4)] of the CYP1A1 from 48 healthy Koreans and 17 Korean lung cancer patients. The mutations were analyzed by polymerase chain reaction (PCR)/restriction fragment length polymorphism (RFLP) and single stand conformation polymorphism (SSCP) simultaneously in order to improve accuracy as well as to screen for possible new alleles. Previously, the m2 mutation has always been linked to the m1 mutation. Also, the m1m2 double mutant allele (*2B) was thought to have a positive correlation with lung cancer susceptibility. Here we report the presence of the solitary m2 mutant allele without the m1 mutation (m1+m2) for the first time. This would be an evidence to support the theory of intragenic recombination in the CYP1A1 locus. The m1 mutation frequencies of healthy Koreans and lung cancer patients were 38.5% and 29.4%, respectively. The m2 mutation frequencies of healthy Koreans and lung cancer patients were 25.0% and 14.7%, respectively. Unlike the case for both Japanese and Caucasian lung cancer patients, neither m1 nor m2 mutations were overrepresented in Korean lung cancer patients. The m2 mutation frequency in Korean patients was significantly higher than those for Caucasians (2.7%) and the Japanese (19.8%). The African-American specific m3 mutation and m4 mutation found in Caucasians were not discovered in this study. The CYP1A1 allele with novel mutation was also not present.
本研究测定了48名健康韩国人和17名韩国肺癌患者的CYP1A1基因的完整基因型以及所有四种突变[T6235C (m1)、A4889G (m2)、T5639C (m3)和C4887A (m4)]的频率。为提高准确性并筛选可能的新等位基因,同时采用聚合酶链反应(PCR)/限制性片段长度多态性(RFLP)和单链构象多态性(SSCP)对突变进行分析。此前,m2突变一直与m1突变相关联。此外,m1m2双突变等位基因(*2B)被认为与肺癌易感性呈正相关。在此,我们首次报告了不存在m1突变的孤立m2突变等位基因(m1+m2)的存在。这将为支持CYP1A1基因座内基因重组理论提供证据。健康韩国人和肺癌患者的m1突变频率分别为38.5%和29.4%。健康韩国人和肺癌患者的m2突变频率分别为25.0%和14.7%。与日本和白种人肺癌患者的情况不同,韩国肺癌患者中m1和m2突变均未过度表达。韩国患者的m2突变频率显著高于白种人(2.7%)和日本人(19.8%)。本研究未发现非裔美国人特有的m3突变以及在白种人中发现的m4突变。也不存在具有新突变的CYP1A1等位基因。